What is the dosage of dabrafenib? How to adjust
Dabrafenib is a targeted therapy drug used to treat BRAF mutation-related cancers. It is commonly used to treat diseases such as advanced melanoma and non-small cell lung cancer. It helps reduce the proliferation of cancer cells and thereby controls tumor growth by inhibiting the function ofBRAF mutant protein. Understanding the correct dosage and method of taking dabrafenib is key to ensuring therapeutic effectiveness.
The recommended dose of dabrafenib is usually 150 mg taken twice daily. This means that patients need to take 300 mg of dabrafenib every day, divided into two doses, morning and evening. Take 150 mg of the drug each time, preferably 1 hour before or 2 hours after meals. This is because the absorption of dabrafenib will be affected by food, and taking it on an empty stomach can improve the bioavailability of the drug, thereby ensuring that the drug achieves the desired therapeutic effect.

For patients already taking dabrafenib, doctors may adjust the dose based on individual response and tolerance. If adverse reactions or side effects occur during treatment, your doctor may reduce the dose or temporarily stop treatment until the side effects are controlled. In addition, factors such as patient age, weight, liver function, and renal function may also affect dose adjustment.
Dabrafenib dose adjustments need to be based on patient tolerance and disease response. For example, when a patient experiences serious adverse reactions (such as rash, fever, nausea, etc.), the doctor may recommend reducing the dose or suspending use until symptoms improve. Often, after these side effects resolve, patients may resume taking the medication, but the dose may be adjusted to a lower level.
During the course of treatment, regular clinical examinations and tests are also crucial, especially tests of liver and kidney function. These indicators can help doctors evaluate the impact of drugs on patients and make appropriate adjustments in a timely manner. If a patient develops abnormalities in liver or kidney function, the doctor may recommend suspending treatment until these problems are resolved.
Reference materials:https://go.drugbank.com/drugs/DB08912
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)